Latest Industry Insights

In this two-part interview series, Technology Networks explores some of the reasons behind the difficulties diagnosing and treating rare diseases, and finds out more about recent developments to improve options for patients.

In this two-part interview series, Technology Networks delves deeper into the diagnostic odyssey many rare disease patients face and explores current efforts to develop improved therapies for these patients.

In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.

Next-generation sequencing (NGS) has undoubtedly revolutionized the genomics field and thanks to technological advances in recent years, laboratories around the globe are now applying NGS to a wide variety of applications. However, library sample preparation remains a key bottleneck and researchers are now looking to adopt automation solutions to alleviate this pain point. Technology Networks recently spoke with Paul Lomax, product manager at SPT Labtech to learn more about firefly^®, the company’s new liquid handling platform for NGS library preparation.

Technology Networks spoke with Michael Yang, president and chief executive officer of ViaCyte, to learn more about the development of a stem cell-derived therapy for the treatment of T1D and the technology behind it.

Laboratories often consume three to 10 times more energy than typical non-laboratory areas of universities. We spoke to Dr Susan Simon of the Medical Research Council to learn more about their commitment to sustainability and transformation to net zero by 2040.

With a reliance on single-use plastics, significant waste and high energy usage, the carbon footprint of the biopharma industry is large. If we are to accelerate the path to net zero, it is therefore critical to ensure sustainability in science.

As we seek a better tomorrow, here are three predictions from global life science and diagnostics company, PerkinElmer, that will lead to better health outcomes.

In this interview, Patrick Brown tells us more about the evolution of NanoDrop over the past 20 years, highlights some of the most important improvements during this time and explores what the future may hold for the technology.

In this interview, we learn about the value of genomic information in conservation efforts to manage endangered populations and how the Wild Genomes program is supporting research in this area.